The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes

Cancer ◽

10.1002/1097-0142(19891101)64:9<1812::aid-cncr2820640909>3.0.co;2-i ◽

1989 ◽

Vol 64 (9) ◽

pp. 1812-1818 ◽

Author(s):

Carlo Aul ◽

Wolfgang Schneider

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Download Full-text

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor and Low-Dose Cytosine-Arabinoside in the Treatment of Patients with Myelodysplastic Syndromes

Oncology Research and Treatment ◽

10.1159/000216716 ◽

1990 ◽

Vol 13 (1) ◽

pp. 33-37 ◽

Author(s):

K. Höffken ◽

F. Overkamp ◽

J. Stirbu ◽

A. Grothey ◽

M. Flasshove ◽

...

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Low Dose ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

Therapeutic Effects of Low-Dose Cytosine Arabinoside, α-Interferon, 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Myelodysplastic Syndromes and Acute Leukemia

Tumor Cell Differentiation ◽

10.1007/978-1-4612-4594-0_14 ◽

1987 ◽

pp. 205-212

Author(s):

Eva Hellström ◽

Karl-Henrik Robèrt ◽

Gösta Gahrton ◽

Håkan Mellstedt ◽

Christina Lindemalm ◽

...

Keyword(s):

Retinoic Acid ◽

Acute Leukemia ◽

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Low Dose ◽

Therapeutic Effects ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3

Download Full-text

Low-Dose Cytosine Arabinoside in Myelodysplastic Syndromes

Acta Clinica Belgica ◽

10.1080/17843286.1989.11717988 ◽

1989 ◽

Vol 44 (1) ◽

pp. 62-63 ◽

Author(s):

Ph. Mineur ◽

Ph. Martiat ◽

A. Ferrant ◽

J.L. Michaux

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Download Full-text

Results of Low-Dose Cytosine Arabinoside and Aggressive Chemotherapy in Patients with Advanced Myelodysplastic Syndromes

Myelodysplastic Syndromes ◽

10.1007/978-3-642-75952-9_40 ◽

1992 ◽

pp. 274-281

Author(s):

C. Aul ◽

W. Schneider

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Download Full-text

Therapeutic Effects of Low-Dose Cytosine Arabinoside Without or With 1,25-Dihydroxyvitamin D3 in Myelodysplastic Syndromes and in Elderly Acute Nonlymphocytic Leukemia

Myelodysplastic Syndromes ◽

10.1007/978-3-642-75952-9_38 ◽

1992 ◽

pp. 263-267

Author(s):

C. Bernasconi ◽

E. P. Alessandrino ◽

P. Bernasconi ◽

M. Lazzarino ◽

D. Inverardi ◽

...

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Low Dose ◽

Therapeutic Effects ◽

Acute Nonlymphocytic Leukemia ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3

Download Full-text

Effect of Treatment with rhGM-CSF and Low-Dose Cytosine Arabinoside on Leukemic Blast Cells in Patients with Myelodysplastic Syndromes

Acute Leukemias II - Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ◽

10.1007/978-3-642-74643-7_138 ◽

1990 ◽

pp. 763-769 ◽

Author(s):

D. Hoelzer ◽

A. Ganser ◽

O. G. Ottmann ◽

K. Höffken ◽

R. Becher ◽

...

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Low Dose ◽

Leukemic Blast ◽

Blast Cells ◽

Effect Of Treatment

Download Full-text

Present Results of the Treatment of Myelodysplastic Syndromes with Low-Dose Cytosine Arabinoside

Acta Haematologica ◽

10.1159/000205914 ◽

1987 ◽

Vol 78 (1) ◽

pp. 109-115 ◽

Author(s):

C. Chomienne ◽

Y. Najean ◽

L. Degos ◽

G. Thomas ◽

E. Baumelou ◽

...

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Download Full-text

GM-CSF Combined with Low-Dose Cytosine Arabinoside: A Trial Proposed for High-Risk Myelodysplastic Syndromes and Results of a Dose-Finding Study

Myelodysplastic Syndromes ◽

10.1007/978-3-642-75952-9_46 ◽

1992 ◽

pp. 321-329

Author(s):

H. H. Gerhartz ◽

H. Schmetzer ◽

B. Wolf-Hornung ◽

A. C. Stern

Keyword(s):

High Risk ◽

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Low Dose ◽

Dose Finding ◽

Gm Csf ◽

Finding Study ◽

Dose Finding Study

Download Full-text

A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes

Annals of Hematology ◽

10.1007/s002770050569 ◽

2000 ◽

Vol 79 (3) ◽

pp. 138-142 ◽

Author(s):

A. Venditti ◽

A. Tamburini ◽

F. Buccisano ◽

M. T. Scimò ◽

G. Del Poeta ◽

...

Keyword(s):

Retinoic Acid ◽

High Risk ◽

Phase Ii ◽

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Low Dose ◽

Phase Ii Trial ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid

Download Full-text

Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes

Irish Journal of Medical Science (1971 -) ◽

10.1007/bf02949309 ◽

1988 ◽

Vol 157 (7) ◽

pp. 238-241 ◽

Author(s):

M. Murray ◽

P. Sarsfield ◽

E. Lawlor ◽

S. R. McCann

Keyword(s):

Myelodysplastic Syndromes ◽

Cytosine Arabinoside ◽

Download Full-text